Chevy Chase Trust
CLB icon

Chevy Chase Trust’s Core Laboratories CLB Stock Holding History

Chevy Chase Trust’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-2,540
Closed -$321K – 673
2018
Q2 		$321K Buy
+2,540
New +$309K ﹤0.01% 621
2017
Q2 		– Sell
-1,747
Closed -$202K – 660
2017
Q1 		$202K Sell
1,747
-164
-9% -$19.1K ﹤0.01% 633
2016
Q4 		$229K Buy
1,911
+117
+7% +$13K ﹤0.01% 629
2016
Q3 		$202K Buy
+1,794
New +$207K ﹤0.01% 628
2015
Q1 		– Sell
-1,684
Closed -$203K – 684
2014
Q4 		$203K Buy
+1,684
New +$221K ﹤0.01% 668

Other funds holding CLB

WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Royal London Asset Management
Royal London Asset Management United Kingdom $54.3B AUM 39.21% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Chevy Chase Trust's CLB Position: Q3 2018 in Review

Chevy Chase Trust sold out of Core Laboratories (CLB) in Q3 2018, closing a stake of 2,540 shares — an estimated $321K sold.

Chevy Chase Trust first reported a position in CLB in Q4 2014 and held it in 5 quarters. The position peaked at $321K in Q2 2018. 359 funds tracked by Wall St. Rank hold CLB as of Q3 2018.

  • Chevy Chase Trust reported no remaining Core Laboratories position as of Q3 2018 after selling out during the quarter.
  • Chevy Chase Trust sold 2,540 Core Laboratories shares in Q3 2018, an estimated $321K.
  • Chevy Chase Trust first reported a position in Core Laboratories in Q4 2014 and held it in 5 quarters.
  • Chevy Chase Trust's Core Laboratories position peaked at $321K in Q2 2018.
  • 359 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2018.

Based on Chevy Chase Trust's 13F filing for Q3 2018, filed 23 Oct 2018.